Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging

Autor: Mustafa R. Bashir, Michiie Sakamoto, Sheng Long Ye, Mengsu Zeng, Carlo Bartolozzi, Elmar M. Merkle, Claude B. Sirlin, Christoph J. Zech, Ahmed Ba-Ssalamah, Alexander Huppertz, Jens Ricke, Jeong Min Lee
Rok vydání: 2016
Předmět:
Adenoma
Gadolinium DTPA
medicine.medical_specialty
Carcinoma
Hepatocellular

Hepatocellular carcinoma
Gadoxetic acid
Clinical Sciences
Contrast Media
Liver mri
030218 nuclear medicine & medical imaging
Adenoma
Liver Cell

Diagnosis
Differential

Cholangiocarcinoma
03 medical and health sciences
0302 clinical medicine
Diagnosis
Liver function tests
Medicine
Humans
Radiology
Nuclear Medicine and imaging

Medical physics
Magnetic Resonance
Neuroradiology
medicine.diagnostic_test
Liver Cell
business.industry
Carcinoma
Liver Neoplasms
Magnetic resonance imaging
Hepatocellular
General Medicine
Magnetic Resonance Imaging
digestive system diseases
Nuclear Medicine & Medical Imaging
Radiology Nuclear Medicine and imaging
Focal Nodular Hyperplasia
030220 oncology & carcinogenesis
Differential
Radiology
business
Precancerous Conditions
Zdroj: European radiology, vol 26, iss 3
European Radiology
Merkle, EM; Zech, CJ; Bartolozzi, C; Bashir, MR; Ba-Ssalamah, A; Huppertz, A; et al.(2015). Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging. European Radiology. doi: 10.1007/s00330-015-3873-2. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/04f3p1rv
Popis: © 2015 The Author(s) Objectives: Liver-specific MRI is a fast-growing field, with technological and protocol advancements providing more robust imaging and allowing a greater depth of information per examination. This article reports the evidence for, and expert thinking on, current challenges in liver-specific MRI, as discussed at the 7th International Forum for Liver MRI, which was held in Shanghai, China, in October 2013. Methods: Topics discussed included the role of gadoxetic acid-enhanced MRI in the differentiation of focal nodular hyperplasia from hepatocellular adenoma and small hepatocellular carcinoma (HCC) from small intrahepatic cholangiocarcinoma (in patients with chronic liver disease), the differentiation of low-grade dysplastic nodule (DN) from pre-malignant high-grade DN and early HCC, and treatment planning and assessment of treatment response for patients with HCC and colorectal liver metastasis. Optimization of the gadoxetic acid-enhanced MRI protocol to gain robust arterial and hepatobiliary phase images was also discussed. Results and conclusions: Gadoxetic acid-enhanced MRI demonstrates added value for the detection and characterization of focal liver lesions and shows promise in a number of new indications, including regional liver functional assessment and patient monitoring after therapy; however, more data are needed in some areas, and further developments are needed to translate cutting-edge techniques into clinical practice. Key Points: • Liver-specific MRI is a fast-growing field, with many technological and protocol advancements.• Gadoxetic acid-enhanced MRI demonstrates value for detecting and characterizing focal liver lesions.• Gadoxetic acid-enhanced MRI shows promise in regional functional assessment and patient monitoring.• Further developments are needed to translate cutting-edge techniques into clinical practice.
Databáze: OpenAIRE